Aims and Scope of Expert Opinion on Drug Metabolism and Toxicology
Expert Opinion on Drug Metabolism & Toxicology is a monthly peer-reviewed medical journal publishing review articles on ADME-Tox. It was established in 2005 and is published by Taylor and Francis. The editor-in-chief is Luis Valerio (Food and Drug Administration). Less
Key Metrics
CiteScore 

7.2
Eigenfactor 

0.005 - 0.01
Impact Factor 

< 5
SJR 

Q1Toxicology

SNIP 

1.21
Recommended pre-submission checks
Powered by 

Topics Covered on Expert Opinion on Drug Metabolism and Toxicology
Expert Opinion on Drug Metabolism and Toxicology Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Drug Metabolism and Toxicology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Expert Opinion on Drug Metabolism and Toxicology
New insights into the role of CYP26 in retinoic acid clearance
- 4 May 2026
- Expert Opinion on Drug Metabolism & Toxicology
Post-marketing pharmacovigilance of tedizolid: emerging safety signals
- 18 Apr 2026
- Expert Opinion on Drug Metabolism & Toxicology
Impact of green tea on pharmacokinetics in cardiovascular therapy: current insights
- 9 Apr 2026
- Expert Opinion on Drug Metabolism & Toxicology
Substrate-specificity of pharmacogenomic variability – clinical relevance and emerging predictive strategies
- 4 Apr 2026
- Expert Opinion on Drug Metabolism & Toxicology
Pregnancy and epilepsy: pharmacokinetic insights into antiseizure medications
- 3 Apr 2026
- Expert Opinion on Drug Metabolism & Toxicology
ADME investigations of novel therapeutic modalities: challenges and opportunities 2025
- 2 Apr 2026
- Expert Opinion on Drug Metabolism & Toxicology
New insights into the role of CYP26 in retinoic acid clearance
- 4 May 2026
- Expert Opinion on Drug Metabolism & Toxicology
Post-marketing pharmacovigilance of tedizolid: emerging safety signals
- 18 Apr 2026
- Expert Opinion on Drug Metabolism & Toxicology
Impact of green tea on pharmacokinetics in cardiovascular therapy: current insights
- 9 Apr 2026
- Expert Opinion on Drug Metabolism & Toxicology
Substrate-specificity of pharmacogenomic variability – clinical relevance and emerging predictive strategies
- 4 Apr 2026
- Expert Opinion on Drug Metabolism & Toxicology
Pregnancy and epilepsy: pharmacokinetic insights into antiseizure medications
- 3 Apr 2026
- Expert Opinion on Drug Metabolism & Toxicology
ADME investigations of novel therapeutic modalities: challenges and opportunities 2025
- 2 Apr 2026
- Expert Opinion on Drug Metabolism & Toxicology